Finzati - Logo
APRE logo

Aprea Therapeutics, Inc.

APRE • Biotechnology
$0.79
▼ -0.01 (-1.49%)
Current price
EarningsLatest report: Jun 30, 2026
BALANCED PROFILENeutralConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Mixed profile. The company is not automatically unattractive, but valuation, growth, or balance-sheet evidence does not yet justify a stronger signal.
Market Cap
$42.48M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Positive revenue growth · 69.2%Manageable debt level · 0Healthy liquidity · 5.63Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 14, 2026, 12:38 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$0.79
Change-1.49%
Shares Out53.48M
Market Cap$42.48M
Enterprise Value$1.25M
52W Range0.55 - 1.75
Beta1.59
P/E-3.45
P/B1.10
P/FCF-3.43
EV/EBITDA-0.09
EV/FCF-0.10

Investment DNA

How strong this company looks for long-term investors

55
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
70/100
Growth Potential
Revenue and expansion
95/100
Price Attractiveness
Cheap or expensive today
95/100
Why this score▼
Positive revenue growth · 69.2%Manageable debt level · 0Healthy liquidity · 5.63Weak profitability

Analyst view

Analyst sentiment and price target

APRE
Analyst sentiment
Based on 8 analyst votes · 2026-09-05
63/100
Neutral
Bullish
4
Hold
2
Bearish
2

Company Overview

IPO: 10/3/2019
Industry: Biotechnology
P/B i: 1.10
Debt / Equity i: 0.00
Operating Margin: 0.00%
Net Margin: 0.00%
ROE i: -
ROIC: -

Financial Health

Score14 / 20
Debt / Equity: 0.00
Current Ratio: 5.63
Quick Ratio: 5.63
Status: Good

Insider Transactions

Recent executive and insider activity

Seizinger Bernd R.
Transaction: 06/16/2026
BUY
Change
+12,555
Price
$0.73
Filing
06/17/2026
Type
BUY
Seizinger Bernd R.
Transaction: 06/16/2026
BUY
Change
+3,135
Price
Not reported
Filing
06/17/2026
Type
BUY
Pamukcu Rifat
Transaction: 06/16/2026
BUY
Change
+3,135
Price
Not reported
Filing
06/17/2026
Type
BUY